Diagnostic algorithms are increasingly helping to tailor therapies for patients. What are the key learnings in building a diagnostic algorithm to personalise therapy for rheumatoid arthritis patients? We talk to Zsolt Hollo, MD, Center of Biotechnology at Egis Pharmaceuticals PLC.
Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives
